Javaid Iqbal

Showing 1-11 of 11 articles

Coronary interventions

Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial

Chichareon P, Onuma Y, van Klaveren D, Modolo R, Kogame N, Takahashi K, Chang C, Tomaniak M, Asano T, Katagiri Y, van Geuns R, Bolognese L, Tumscitz C, Vrolix M, Petrov I, Garg S, Naber C, Sabaté M, Iqbal J, Wykrzykowska J, Piek J, Spitzer E, Jüni P, Hamm C, Steg P, Valgimigli M, Vranckx P, Windecker S, Serruys P

August 9, 2019 | 10.4244/EIJ-D-19-00184

Coronary interventions

State of the art: optimal medical therapy – competing with or complementary to revascularisation in patients with coronary artery disease?

Iqbal J, Widmer R, Gersh B

August 25, 2017 | 10.4244/EIJ-D-17-00463

Coronary interventions

DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial

Iqbal J, Verheye S, Abizaid A, Ormiston J, De Vries T, Morrison L, Toyloy S, Fitzgerald P, Windecker S, Serruys P

December 9, 2016 | 10.4244/EIJY15M10_04

Coronary interventions

Clinical outcomes of “complete, partially complete, and incomplete” revascularisation at five-year follow-up after percutaneous intervention of unprotected left main coronary artery disease with drug-eluting stents

Zhang Y-J, Iqbal J, Ye F, Zhang J, Bourantas C, Pan D-R, Tian N, Kan J, Qian X-S, Ding S, Li F, Zhang A, Liu Y, Muramatsu T, Onuma Y, Garcia-Garcia H, Serruys P, Chen S

October 10, 2016 | 10.4244/EIJY15M12_06

Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial

Nakatani S, Onuma Y, Ishibashi Y, Muramatsu T, Iqbal J, Zhang Y-J, van Geuns R, Ormiston J, Serruys P

March 20, 2015 | 10.4244/EIJV10I11A218

3D optical coherence tomography: new insights into the process of optimal rewiring of side branches during bifurcational stenting

Okamura T, Onuma Y, Yamada J, Iqbal J, Tateishi H, Nao T, Oda T, Maeda T, Nakamura T, Miura T, Yano M, Serruys P

December 22, 2014 | 10.4244/EIJV10I8A157

Comparison of acute gain and late lumen loss after PCI with bioresorbable vascular scaffolds versus everolimus-eluting stents: an exploratory observational study prior to a randomised trial

Zhang Y-J, Bourantas C, Muramatsu T, Iqbal J, Farooq V, Diletti R, Campos C, Onuma Y, Garcia-Garcia H, Serruys P

October 20, 2014 | 10.4244/EIJV10I6A118

Coronary stents seeded with human trophoblastic endovascular progenitor cells show accelerated strut coverage without excessive neointimal proliferation in a porcine model

Raina T, Iqbal J, Arnold N, Moore H, Aflatoonian B, Walsh J, Whitehouse S, Al-Lamee K, Francis S, Gunn J

October 20, 2014 | 10.4244/EIJV10I6A123

Lessons learned from acute and late scaffold failures in the ABSORB EXTEND trial

Ishibashi Y, Onuma Y, Muramatsu T, Nakatani S, Iqbal J, Garcia-Garcia H, Bartorelli A, Whitbourn R, Abizaid A, Serruys P

August 19, 2014 | 10.4244/EIJV10I4A78

Transcatheter aortic valve update 2013

Bourantas C, Van Mieghem N, Soliman O, Campos C, Iqbal J, Serruys P

September 15, 2013 | 10.4244/EIJV9SSA16

Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting

Iqbal J, Sumaya W, Tatman V, Parviz Y, Morton A, Grech E, Campbell S, Storey R, Gunn J

May 21, 2013 | 10.4244/EIJV9I1A10

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...